LEXINGTON, Mass.--(BUSINESS WIRE)--Critical Therapeutics, Inc. (Nasdaq: CRTX), a biopharmaceutical company focused on developing and commercializing innovative products for respiratory, inflammatory and critical care diseases, today announced that it has rescheduled the date on which it plans to release its fourth-quarter and year-end 2007 financial results. In light of the Company’s ongoing review of strategic alternatives and its recent announcement regarding the transition of management, it has decided to reschedule the announcement of its fourth-quarter and year-end 2007 financial results to the week of March 24, 2008. The Company had previously scheduled the announcement of its fourth-quarter and year-end 2007 financial results and conference call for March 13, 2008.
